Clinical Gastroenterology and Hepatology 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Prostate Cancer Masquerading as Colon Adenocarcinoma
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 13, 2022 Category: Gastroenterology Authors: Preet Patel, Cheng Huang, Erik C. von Rosenvinge Tags: Image of the Month Source Type: research
Induction efficacy of upadacitinib in therapy-refractory crohn ’s disease - a retrospective case series
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 12, 2022 Category: Gastroenterology Authors: Pokryszka Jagoda, Reinisch Sieglinde, Primas Christian, Novacek Gottfried, Reinisch Walter Source Type: research
Dibothriocephalus nihonkaiensis incidentally detected at colonoscopy
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 12, 2022 Category: Gastroenterology Authors: Kimitoshi Kubo, Mototsugu Kato, Yasuhiko Sako Tags: Image of the Month Source Type: research
Some issues considered for clip closure after endoscopic resection of large serrated polyps
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 12, 2022 Category: Gastroenterology Authors: Qing Lu, Xiu-He Lv, Jin-Lin Yang Source Type: research
Spleen size does not correlate with histological stage of liver disease in people with non-alcoholic fatty liver disease
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 12, 2022 Category: Gastroenterology Authors: Tessa M. Cacciottolo, Anupa Kumar, Edmund M. Godfrey, Susan E. Davies, Michael Allison Source Type: research
Reply to “Body-mass index and PNPLA3 genetic variant modify the association of alcohol consumption with liver fat content”
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 12, 2022 Category: Gastroenterology Authors: Antonio De Vincentis, Federica Tavaglione, Stefano Romeo, Umberto Vespasiani-Gentilucci Source Type: research
What Faculty and Fellows Should Know About Milestones 2.0
This article highlights new features of the gastroenterology (GI) and hepatology milestones and provides action items for programs from a faculty and a fellow perspective. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 11, 2022 Category: Gastroenterology Authors: Lauren L. Donnangelo, Brijen Shah Tags: Educator and Trainee Perspectives Source Type: research
Risk Factors for Incident Inflammatory Bowel Disease According to Disease Phenotype
We examined whether relationships between known risk factors for Crohn ’s disease (CD) and ulcerative colitis (UC) differ according to disease phenotype, defined by Montreal classification, at the time of diagnosis. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 11, 2022 Category: Gastroenterology Authors: Emily W. Lopes, Paul Lochhead, Kristin E. Burke, James M. Richter, Ashwin N. Ananthakrishnan, Andrew T. Chan, Hamed Khalili Source Type: research
Fenofibrate Mitigates Hypertriglyceridemia in Nonalcoholic Steatohepatitis Patients Treated With Cilofexor/Firsocostat
Patients with advanced fibrosis due to nonalcoholic steatohepatitis (NASH) are at high risk of morbidity and mortality. We previously found that a combination of the farnesoid X receptor agonist cilofexor (CILO) and the acetyl-CoA carboxylase (ACC) inhibitor firsocostat (FIR) improved liver histology and biomarkers in NASH with advanced fibrosis but was associated with hypertriglyceridemia. We evaluated the safety and efficacy of icosapent ethyl (Vascepa ®) and fenofibrate to mitigate triglyceride elevations in NASH patients treated with CILO and FIR. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 6, 2022 Category: Gastroenterology Authors: Eric J. Lawitz, Bal Raj Bhandari, Peter J. Ruane, Anita Kohli, Eliza Harting, Dora Ding, Jen-Chieh Chuang, Ryan S. Huss, Chuhan Chung, Robert P. Myers, Rohit Loomba Source Type: research
Association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease in NAFLD
This study investigated the association of physical activity with risk of liver fibrosis, sarcopenia, and cardiovascular disease (CVD) in NAFLD. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 5, 2022 Category: Gastroenterology Authors: Ho Soo Chun, Minjong Lee, Hye Ah Lee, Seo Yeong Oh, Hyo Jeong Baek, Jae Won Moon, Yeon Jeong Kim, Jinha Lee, Hyoeun Kim, Hwi Young Kim, Kwon Yoo, Tae Hun Kim, Seung Up Kim Source Type: research
Antibody Response Six Months after SARS-CoV-2 mRNA Vaccination in Patients with Inflammatory Bowel Disease
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 5, 2022 Category: Gastroenterology Authors: Sarah Frey, Reezwana Chowdhury, Caoilfhionn M. Connolly, William A. Werbel, Dorry L. Segev, Alyssa M. Parian, IBD Group, Evangelos Tsipotis, Sharon Dudley-Brown, Mark Lazarev, Joanna M. Melia, Brindusa Truta, Huimin Yu, Florin M. Selaru Source Type: research
Severe Bleeding Gastric Barotrauma Unmasking Collagenous Gastritis
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 5, 2022 Category: Gastroenterology Authors: Kenneth Leung, Irene Thung, Muhammad Bader Hammami Tags: Image of the Month Source Type: research
QuickStroop, a Shortened Version of EncephalApp, Detects Covert Hepatic Encephalopathy with Similar Accuracy within One Minute
Covert Hepatic Encephalopathy (CHE) is associated with poor outcomes but is often not diagnosed due to the time requirement. Psychometric hepatic encephalopathy (PHES) is the gold standard against which EncephalApp Stroop has been validated. However, EncephalApp (5 runs each in “Off” and “On” state) can take up to 10 minutes. Aim: Define the smallest number of EncephalApp runs needed for comparable accuracy to as the total EncephalApp using CHE on PHES as gold standard. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 5, 2022 Category: Gastroenterology Authors: Chathur Acharya, Jawaid Shaw, Nikki Duong, Andrew Fagan, Sara McGeorge, James B. Wade, Leroy R. Thacker, Jasmohan S. Bajaj Source Type: research
Can a Defecation Posture Modifying Device Correct an Abnormal Balloon Expulsion Test in Chronically Constipated Patients?
(Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 5, 2022 Category: Gastroenterology Authors: Eden Koo, William D. Chey, Gabrielle Ezell, Jason R. Baker, Moira Armstrong, Borko Nojkov Source Type: research
Prevalence and Implications of Frailty in Older Adults with Incident Inflammatory Bowel Diseases: a Nationwide Cohort Study
We aimed to compare the risk of frailty in older adults with incident inflammatory bowel disease (IBD) and matched non-IBD comparators and assess the association between frailty and future hospitalizations and mortality. (Source: Clinical Gastroenterology and Hepatology)
Source: Clinical Gastroenterology and Hepatology - January 5, 2022 Category: Gastroenterology Authors: Bharati Kochar, Juulia Jylh ävä, Jonas Söderling, Christine S. Ritchie, the SWIBREG study group, Jonas F. Ludvigsson, Hamed Khalili, Ola Olén Source Type: research
